Don't miss an issue! Renew/subscribe for FREE today.
×

11,000+ Registrants Make AAO History With First-Ever Virtual Annual Session, Record-Breaking Numbers

Posted on Wednesday, May 6, 2020

The American Association of Orthodontists brought the orthodontic community together for its premier online event – AAO 2020: A Virtual Experience – May 2-3.

The record-breaking event had the highest number of doctors registered in AAO history. With a total of 11,222 registrants and 93 countries represented, the event lived up to the title of the largest annual celebration of orthodontics in the world.

“AAO members made this a resounding success by embracing this event, lending their talents as speakers and moderators and participating in record numbers,” said Dr. Gary Inman, AAO president.

Attendees heard keynotes from Dr. Neal Kravitz, Dr. Kyle Fagala and Dr. Anil Idiculla, as well as 12 clinical, 15 practice management and 15 exhibitor lectures from world-renowned orthodontists and industry leaders.

Lecture highlights included 5 Important Considerations to Achieve Predictable Outcomes with Clear Aligner Therapy by Dr. Mazyar Moshiri; Is Virtual Our New Reality? Virtual Orthodontic Visits Before, During and After a Global Pandemic by Dr. Daniel Bills; and The Clinical Side of Two-Phase Treatments by Dr. Silvia Allegrini.

“Our goal was to bring the orthodontic community together with keynotes, happy hours and an awards ceremony, all while providing our members with an opportunity to get CE and connect with suppliers at no cost during this challenging time,” Dr. Inman said. “What ended up happening was far more than we could have ever expected. We overwhelmingly saw the orthodontic community unite over an incredible weekend of learning.”

Attendees qualified for access to 12 CE credits – all from the comfort of their own homes – and those who stuck around for AAOF sponsored programming accessed an additional 3 lectures and CE credits.

The event was free to AAO members and open to non-members for purchase. Attendees viewed the event alongside family and pets. Relive the event via Instagram.

The AAO is set to meet in Boston, Massachusetts, on April 23-27 for AAO 2021. More details and registration will be available in the fall.

The American Association of Orthodontists represents 19,000 orthodontist members throughout the United States, Canada and abroad. Founded in 1900, AAO is the world’s oldest and largest dental specialty organization. AAO is dedicated to, among other goals: (a) ethically advancing the art and science of orthodontics and dentofacial orthopedics worldwide; (b) improving the health of the public by promoting quality orthodontic care, the importance of overall oral healthcare, and advocating for the public interest; and (c) educating the public about the benefits of orthodontic treatment and the educational qualifications of orthodontic specialists. For more information, visit aaoinfo.org.







OperaDDS Partners With Benco Dental to Provide New, Fast-to-Implement Tech Tools for Teledentistry and COVID-19 Screening

Posted on Wednesday, May 6, 2020

 

 

Benco Dental will offer the company's software-based safeguards for team members and patients as part of its Benco Practice Solutions suite of products. Most offices will be up and running in 48 hours or less.


Benco Dental is teaming with OperaDDS, a leading provider of HIPAA-compliant intra-office communication tools, to provide customers with enhanced access to screening and teledentistry solutions developed specifically to help practices respond more effectively to the changing environment of dentistry amid COVID-19.

OperaDDS is already well known for developing intuitive-to-use, time-saving and stress-reducing solutions for forms, recall, chat, email and more—with a unique emphasis on security and HIPAA compliance. The company's new COVID-19 Pre-Appointment Screening And Teledentistry Kit is a two-step answer to adding necessary screening and reducing unnecessary interaction to help keep team members and patients safe:

• Step 1: Pre-Screen Patients For COVID-19. Prior to each appointment, use OperaDDS to email or text a COVID-19 screening form based on current CDC guidelines so you and your team can make critical decisions regarding at-risk patients before they arrive.

•Step 2: Use A Teledentistry Emergency Triage Form. This form can be easily texted or emailed and allows patients to securely send photos and videos of their issue to reduce unnecessary emergency appointments and exposure, and reduce the burden and exposure of your team.

"The way doctors and patients communicate is changing fast by necessity, and more people will be sharing information electronically than ever before," said Dr. Bryan Laskin, owner and founder of OperaDDS. "Our solutions ensure they can do so confidently, and also easily, since many patients with limited technology exposure will need to adapt."

OperaDDS users will have access to a full range of synchronous and asynchronous options for safely connecting to share information, photos and video. "It's really about making available the best choice for any given situation," explained Dr. Laskin. "Live teledentistry works in some situations, but in others, asynchronous sharing of photos and information offers more flexibility and comfort."

Ryan Rinaldi, Product Manager for Benco Practice Solutions, said, "OperaDDS is the right teledentistry product for our customers at this time. Benco Dental is pleased to add it to our growing list of innovative solutions for all of the challenges today's dental practices face. OperaDDS is affordable, adaptable, provides choice, saves time and reduces stress. All of those things are more important than ever. We think it adds considerable value as dentists nationwide look for a way forward in today's new normal."

For a demonstration or to learn more, please contact your Friendly Benco Rep, call 1.800.GO.BENCO or visit benco.com. For a limited time, customers who sign up get one month free, plus setup fees are waived. No contract is required, and plans begin at just $89 per month after the first month.

CAPTION:

operadds.png: Every tool in the OperaDDS suite is designed with HIPAA compliance in mind.

ABOUT OPERADDS

Thousands of dental practices use OperaDDS, an intra-office communication system that's easily accessible but also HIPAA-compliant. Its creator, Dr. Bryan Laskin, is a practicing dentist and owner of Lake Minnetonka Dental. He's also a member of the Minnesota Department of Health's ePrivacy and Security Workgroup. From forms and recall, to new tools for practicing amid COVID-19, OperaDDS is a constantly evolving software solution uniquely focused on privacy, security and intuitive usefulness.

ABOUT BENCO DENTAL

Benco Dental is Driving Dentistry ForwardSM with innovative solutions and our caring family culture. Our industry firsts include Painless® electronic ordering, automated supply management, BluChip® customer loyalty rewards, CenterPoint design/equipment superstores and OneVisitTM open architecture CAD/CAM. Independent since 1930, our over 1,500 dedicated associates serve customers at locations nationwide including 400+ sales representatives and 300+ factory-trained service technicians. Benco Dental is one of Fortune's Best Workplaces in Health Care and Biopharma. For more information, visit benco.com or call 1.800.GO.BENCO.

For more information, visit benco.com or call 1.800.GO.BENCO.

 

 







ioTech International to Protect Healthcare Workers From COVID-19 Exposure With Molecular Iodine in Controlled Study

Posted on Wednesday, May 6, 2020

ioTech International announced today that three of its products, based on patented, proprietary, non-staining formulations of molecular iodine, are being used in an IRB approved, controlled clinical trial that was just initiated at St. Joseph's Hospital University Medical Center in Patterson, NJ. The products being evaluated are ioRinse Oral Rinse, ioCleanse Hand Cleanser and ioMist Nasal Spray. Each of these unique, high performance products utilize ioTech's patented molecular iodine technology. The trial is being led by Dr. Hillel Ephros, Chairman, Department of Dentistry/OMS. Program Director, Oral & Maxillofacial Surgery. Medical Director, The Regional Craniofacial Center. The endpoint of the six-week study will be a reduction in COVID-19 symptoms from healthcare workers who are using the ioTech products and are treating novel coronavirus patients compared to the control group.

"We are excited to start using ioTech's molecular iodine products in order to provide a critical extra layer of protection going beyond the CDCs recommended usage of PPE, soap & water and hand sanitizer. Using ioTech International's proprietary molecular iodine formulations enables St. Joseph Hospital to protect our medical staff by providing a highly effective antiviral that has displayed rapid and complete efficacy against Coronavirus (strain #229E) and other tenacious viruses in independent laboratory testing," said Dr. Ephros.

"ioTech International's proprietary formulations deliver up to 100 times more of the biocidal active, molecular iodine than povidone iodine alone, demonstrating profound antiviral activity across a wide range of difficult-to-kill pathogens," said Rodger Kolsky, Co-Founder and Director of R&D.  Dr. Herb Moskowitz, ioTech International Inc's Co-founder and Chairman commented, "Reviewing the compelling results from multiple studies, we are confident that molecular iodine will play an important preventive and therapeutic role in helping to control the current COVID-19 pandemic."

Study Design

The clinical trial was designed to evaluate efficacy of ioTech International 's molecular iodine on skin and mucosa as an additional barrier to PPE for the transmission of COVID-19 to St. Joseph's Hospital employees engaged in patient care. The six week, two -arm randomized control study compares a control group of 300 employees following CDC guidelines versus 300 employees following CDC guidelines with adjunctive molecular iodine usage of oral rinse, nasal spray and hand sanitizer. A comparison of the control group versus active study group is the following:

Arm 1 Control

   • Follow CDC guidelines at home and work.

   • Take temperature twice daily at same time, ideally 12 hours apart.

   • Complete the symptom checklist once daily for the entire duration of the study.

   • If symptoms develop that suggest COVID-19 and/or a fever of over 100.4F is noted, COVID-19 testing should be done.

Arm 2 Control

   • Follow CDC guidelines at home and work.

   • In addition, use molecular iodine hand sanitizer as directed 4 times daily whether at work or at home: on work days, use prior work shift, during breaks and after the shift as well as after any suspected potential exposure due to PPE failure/inadequacy.

   • In addition, gargle with provided oral rinse as directed 4 times daily whether at work or at home: on work days, gargle prior to each work shift, during breaks and after the shift as well as after any suspected potential exposure due to PPE failure/inadequacy.

   • In addition, use provided nasal spray as directed 4 times daily whether at work or at home: on work days, use nasal spray prior to each work shift, during breaks and after the shift as well as after any suspected potential exposure due to PPE failure/inadequacy.

   • Take temperature twice daily at same time, ideally 12 hours apart.

   • Complete the symptoms checklist once daily for the enture duration of the study.

   • If symptoms develop that suggest COVID-19 and/or a fever of over 100.4F is noted, COVID-19 testing should be done.

Discontinuation

The investigator will terminate a participant, if the participant fails to report for three consecutive days of reporting; the participants can withdraw their participation without penalty or threat of future care. The Investigator will be notified of anyone's intention to discontinue.

About ioTech International?

ioTech International is a world leader in molecular iodine research and development. Its patented, breakthrough germicidal products are marketed under the brand names of ioRinse, ioCleanse, ioGel and ioMIST. ioRinse ready to use oral mouth rinse comes in 2 flavors and is recommended for twice daily use. ioCleanse hand cleanser spray is sprayed onto hands and then rubbed vigorously for 30-seconds until dry. ioMIST is a nasal spray inhaled through the nose. Each high-performance, unique product features ioTech's breakthrough, antimicrobial molecular iodine technology. ioTech International products can be found at iotechinternational.com.







Ultradent Announces Partnership to Supply Meals for Furloughed/Laid Off Employees

Posted on Tuesday, May 5, 2020

Ultradent Products, Inc., is partnering with Four Foods Group to offer free meals to members of the Ultradent family who have been laid off or furloughed as a result of COVID-19 related changes.

The Relief Packs program provides meals from local eateries at no cost to the recipient, courtesy of generous public donations and the efforts from Four Foods Group—along with Ultradent employees.

“We’re exploring all possible ways to help our employees impacted by budget cuts and we’re thankful to be working with Four Foods Group and their Relief Packs program,” says Ultradent President Dirk Jeffs. “Our hearts go out to all those affected by this pandemic. We’re taking every effort to minimize impacts on our employees, and we hope this program helps those going through tough times.”

Recipients of the Reliefs Packs program are able to select meals from R&R BBQ, Costa Vida Fresh Mexican Grill, and Mo’ Bettahs.

Ultradent employees are able to help their laid off and furloughed colleagues by donating to the Relief Packs program.

About Ultradent Products, Inc.

Ultradent Products, Inc., is a leading developer and manufacturer of high-tech dental materials, devices, and instruments worldwide. Ultradent’s vision is to improve oral health globally. Ultradent also works to improve the quality of life and health of individuals through financial and charitable programs. For more information about Ultradent, call 800.552.5512 or visit ultradent.com.







Ultradent Offers Free CE Through New Online Portal

Posted on Tuesday, May 5, 2020

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is offering free online continuing education (CE) courses as a response to travel and gathering restrictions in place due to COVID-19.

The courses can be accessed at https://ultradent.teachable.com/courses/ and the portal is continually being updated as new courses become available.

Featured courses currently include:

   • Tips and Tricks in Esthetic Anterior Restorations by Dr. Rafael Beolchi

   • Clinical Applications of the Two ‘Faces’ of the Gemini Laser by Dr. Michael A. Miyasaki

   • Dental Technology: The Gateway to the Path of Excellence by Dr. Ron Kaminer

   • A Quality Hygiene-Oriented Practice Equates to Recession-Proof Dentistry by Dr. Lou Graham

   • Incorporating Laser Dentistry into Your Practice by Dr. Ana Cecilia Aranha

“Ultradent is very pleased to offer these free online CE courses as part of our long-standing focus on education,” says Ultradent’s Director of Field Marketing, Jack Phillips. “We look forward to continuing partnering with you, your practice, and your staff in an effort to pursue Ultradent’s mission of improving oral health globally.”

Upcoming courses will include Light Curing: The Key to Longevity by Dr. Beolchi and The New Norm by Dr. Graham and Dr. Kaminer, which will focus on COVID-19 related topics.

About Ultradent Products, Inc.

Ultradent Products, Inc., is a leading developer and manufacturer of high-tech dental materials, devices, and instruments worldwide. Ultradent’s vision is to improve oral health globally. Ultradent also works to improve the quality of life and health of individuals through financial and charitable programs. For more information about Ultradent, call 800.552.5512 or visit ultradent.com.

 







Ultradent Donates 12,000 Disposable Face Masks to University of Utah Health

Posted on Tuesday, May 5, 2020

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials, is donating 12,000 disposable face masks to University of Utah Health.

The donation of disposable facemasks will help mitigate the shortage of personal protective equipment (PPE) for front line professionals battling the COVID-19 pandemic.

“We’re all deeply indebted to the medical professionals saving lives and reducing suffering caused by this pandemic,” says Ultradent President, Dirk Jeffs. “The work being done both in Utah and around the world is admirable. We’re hoping these masks will help our Utah neighbors in their fight against this virus.”

The Utah Coronavirus Task Force (along with multiple state legislators) issued a request for businesses to donate PPE including disposable face masks.

“From the bottom of our hearts, the University of Utah Health team expresses our deep appreciation for the generous outpouring from community members as they find ways to support and protect our health care workers during the COVID-19 pandemic,” says University of Utah Health’s Executive Director of Network Development and Telehealth, Tad Morley. “We are especially thankful for the generosity of local businesses, which give even while many are suffering themselves during this time. Ultradent Products Inc.’s donation of 12,000 disposable face masks will give U of U Health care workers the protection they need while they work to help prevent the spread of COVID-19.”

About Ultradent Products, Inc.

Ultradent Products, Inc., is a leading developer and manufacturer of high-tech dental materials, devices, and instruments worldwide. Ultradent’s vision is to improve oral health globally. Ultradent also works to improve the quality of life and health of individuals through financial and charitable programs. For more information about Ultradent, call 800.552.5512 or visit ultradent.com.







Waterlase Dental Laser Meets Suggested Guidelines to Minimize Risk of COVID-19 Transmission Through Reduced Aerosol Production

Posted on Tuesday, May 5, 2020

 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that as dental offices plan to reopen, recent guidance from the American Dental Association (ADA) recommends reducing aerosol production as much as possible to help prevent transmission of COVID-19. A key component of aerosol production is water usage. During this critical time, dentists can rely on Waterlase dental lasers, which use 80% less water compared to traditional dental handpieces.

"During this pandemic, it is important to lean on any and all resources that could potentially limit the spread of the virus," said Todd Norbe, CEO of BIOLASE. "We are proud to be a part of the solution for dental professionals looking to treat their patients in the safest way possible. Providing dentists with innovative solutions to keep their practice moving forward directly aligns with our mission of advancing dentistry and ensuring patients and dentists have less to worry about during procedures."

Waterlase is a minimally invasive dental laser that allows dental professionals to perform more procedures in a quicker amount of time. The laser can be used for multiple procedures, including cavity preparation, periodontal procedures, restorations, gingivectomies, frenectomies and more. The Waterlase combines water, air and laser energy for a more gentle experience, limiting the need for anesthetics, and promoting quicker healing times.

Learn more about Waterlase at BIOLASE.com/LessIsMore.

About BIOLASE, Inc.

BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 41,000 laser systems to date in over 80 countries around the world.







Study Shows Need for New Focus in Anti-Vaping Efforts for Teens & Young Adults

Posted on Tuesday, May 5, 2020

They know it’s addictive. They know it’s linked to dangerous and even fatal lung diseases. And they know it delivers far more nicotine than the cigarettes it’s supposed to replace.

But the social aspects of vaping drives young people to use Juul and other e-cigarettes, according to nearly two-thirds of teens and young adults in a new study. Less than 5% say the availability of fruity flavors drives use of e-cigarettes by members of their generation, and only 10% say that addiction does.

The findings, published in a research letter in JAMA Pediatrics, come from a text-message-based survey of teens and young adults between the ages of 14 and 24 conducted by the University of Michigan’s MyVoice study.

The survey was conducted before the 2019 epidemic of vaping-associated lung injury, and long before suggestions that COVID-19 might pose a greater risk to people who smoke or vape. It was also conducted before the federal ban on sales of all vaping products to people under the age of 21, and on the sale of fruit-flavored vaping pods, but not vaping liquids.

But it still sheds light on what kinds of messaging and interventions might be needed to reduce e-cigarette use in in youths, says senior author Tammy Chang, M.D., M.P.H., M.S.., an assistant professor of family medicine at Michigan Medicine, U-M’s academic medical center.

“It’s not just about the flavors, it’s about understanding the motivations for using these products, and their attitudes toward risk,” says Chang, a member of the U-M Institute for Healthcare Policy and Innovation. “They’re more savvy than we think they are, and they’re using it because it’s about being cool and about the experimentation that happens naturally in adolescence. Reducing teen and young adult use of these products, especially under current policies, will require an evidence-based approach.”

Assessing knowledge and attitudes

The survey used “juuling” as the term for the activity of using Juul and other e-cigarettes. It asked a nationally representative sample of teens and young adults four questions, and allowed them to answer however they liked. In all, 1,129 young people answered – 92% of those who have volunteered to receive occasional text surveys from the MyVoice study.

In all, 79% of the respondents said they think juuling is dangerous, and another 7% said it might be. Nearly 72% believe it can lead to use of other substances, including cigarettes and other drugs, and one in four of the rest of the respondents said that people who juul already use other substances.

Georgia Wood, the lead author and undergraduate student at U-M, said: “These findings are critically important because it describes the lived experiences of youth related to Juul, which has been missing. This is the kind of information we need to create policies and programs that work. Youth are depending on us to do that.”

“For policymakers and public health officials who want to focus prevention and cessation messages on the health risks, or who think that bans on flavors will be the answer, these data show that ship has sailed,” says Chang. “We need to use what we now know about what drives youth behavior, and put teeth behind the enforcement of sales bans as we have with alcohol.”

Chang notes that other research has shown that vaping spiked among young people in the past few years, just as smoking of cigarettes had gone down to record low levels. “The message about the dangers of smoking tobacco was just getting through, and then vaping came along and we may now have a whole new generation addicted to nicotine,” she says.

Younger vs. older youths

The study broke respondents up by age group. While 14- to 17-year olds were somewhat more likely to have heard of Juul, 84% of the 18-24-year-olds also had heard of it. Young respondents were also somewhat more likely to say that social factors were the main reason that people their age use e-cigarettes, but 58% of older respondents also said this.

The two age groups were about the same in their perceptions of danger from vaping, including nicotine intake, physical health effects and addiction. The same was true for their opinions about whether vaping leads to use of other substances.

Chang notes that more research needs to be done on how to help young people cut down on or stop using e-cigarettes, especially given the fact that nicotine replacement products like gums and patches are not approved for people under 18. In the meantime, young people can talk to health providers about whether those products are right for them.

Future directions

More research is needed on the effects of bans on sales of vaping products to people under 21, and sales of flavored pods, Chang says -- as well as on the effect of the COVID-19 pandemic on access to vape shops that sell the bulk liquids used in non-pod devices. So is more research on patterns of cigarette use by young people, after these changes, she adds.

Meanwhile, enforcement of those new rules will become more important, she says.

“As a society, we need to do the baseline job of cutting back on the potential supply of nicotine in all its forms to young people, while allowing adults who use vaping as a means of reducing cigarette use to continue to have access,” she says. “We need to focus on penalizing those who sell these products to people under 21, in any setting and any form, so that we can keep an addictive drug out of the hands of adolescents who are naturally seeking to experiment as part of their development.”

At the same time, vaping-related messaging to young people as early as middle school should focus on social factors, Chang says. This could include positive identity development that focuses on individual strengths instead of the need to be cool or belong to a social group that emphasizes vaping.

“We need to start our conversations with youth from this perspective – and start it early,” she says.

In addition to Wood and Chang, the study’s authors are Marika E.Waselewski, MPH, of the Department of Family Medicine; medical student Arrice C. Bryant, BA, and Kendrin R. Sonneville, ScD, RD of the U-M School of Public Health. The study is funded by the Michigan Institute for Clinical & Health Research, the U-M MCubed program, and the U-M Department of Family Medicine.

Study: JAMA Pediatrics, doi:10.1001/jamapediatrics.2020.0491  







American Association of Endodontists Announces New President Dr. Alan H. Gluskin

Posted on Tuesday, May 5, 2020

The American Association of Endodontists (AAE), the 8,000-plus-member association representing dental specialists known as endodontists, is announcing that Alan H. Gluskin, D.D.S., will serve as its new President, effective April 30, 2020. Dr. Gluskin succeeds Dr. Keith V. Krell. AAE Presidents serve one-year terms and are elected by Association stakeholders.

The transfer of leadership comes during a period when health care providers here and abroad are facing unprecedented times. Endodontists who save teeth by way of root canal treatment are also highly sought after in times of dental emergencies.

“Since its formation, the AAE has been fortunate to have been led by so many incredible leaders in endodontics and dentistry year after year,” said AAE Executive Director Ken Widelka, CAE, FACHE, CPA. “Dr. Gluskin has served the Association in many capacities, and I look forward to our continued work to strengthen the AAE, its membership, the endodontic specialty and patient wellness.”

“I am honored to continue serving the AAE in my new role as its president,” Dr. Gluskin said. “The AAE is a superb organization of endodontists, their practice staff throughout the world and our own Association staff based in Chicago – all working to better the specialty and patient health. I am grateful to immediate past president Dr. Keith V. Krell for his contributions to the AAE and I look forward to leading the Association.”

Dr. Gluskin graduated from the University of the Pacific School of Dentistry, San Francisco, in 1972. Before receiving his Endodontic Certification from Temple University in Philadelphia in 1976, Dr. Gluskin spent two years as a general dentist. He has served the endodontic specialty in a variety of roles. He became President of the AAE during the COVID-19 pandemic and vows to continue prioritizing support for endodontists and their patients.

“The AAE is committed to continuing to create and curate helpful resources from a variety of trusted sources to help practitioners make decisions quickly and communicate with patients effectively,” Dr. Gluskin continued. “As I serve in my new role, I want to remind our members and their patients that the AAE is here for them – by promoting endodontics and health care as mutually important.”

Dr. Gluskin served as one of the organizing authors on the AAE’s Endodontic Competency and Treatment Standards white papers. He promises to spend his presidential year promoting endodontics and advocating for endodontists. Dr. Gluskin is professor and vice-chair, Department of Endodontics, at the Arthur A. Dugoni School of Dentistry, University of the Pacific, in San Francisco. He is at present a Fellow of the International College of Dentists and the American College of Dentists.

He is also a member of numerous societies, including the American Dental Association and the San Francisco Dental Society. He has served on the Educational Affairs Committee and the Research and Scientific Affairs Committee of the AAE, as well as the Editorial Board of the Journal of Endodontics and as general chair for both AAE10 and AAE18. Additionally, he is the 2017 recipient of the University of the Pacific’s Eberhardt Teacher-Scholar Award and co-editor of the textbooks, Decision Making in Dental Treatment Planning and Practical Lessons in Endodontic Treatment.

About the American Association of Endodontists

The American Association of Endodontists, headquartered in Chicago, represents more than 8,000 members worldwide. Endodontics is one of 12 dental specialties formally recognized by the American Dental Association. The AAE, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care. The Association inspires its members to pursue professional advancement and personal fulfillment through education, research, advocacy, leadership, communication and service. For more information about the AAE, visit the Association's website at aae.org.

   







MMG Fusion Completes Integration with Curve Dental

Posted on Tuesday, May 5, 2020

MMG Fusion, the all-in-one software suite working to Market, Manage, and Grow dental practices, has completed their integration with partner Curve Dental, the leading provider of cloud-based dental solutions. The integration makes MMG Fusion's broad offering of 4x Best of Class winning patient engagement and practice marketing software available to Curve Dental's tech-savvy customers. "During this unique crisis, Curve Dental customers need full access to the most advanced patient communication and marketing tracking software that demonstrates their ability to keep their staff and patients safe before, during, and after each appointment. Practices must effectively communicate and engage with their patient base now, while also implementing cost saving measures to prepare for their eventual return to business," said Paul Intlekofer, CEO of MMG Fusion. "Both MMG Fusion and Curve Dental are dedicated to providing these tools to our customers so they can hit the ground running when business resumes."

By integrating with MMG Fusion, Curve Dental can offer its over 27,000 dental professionals even more ways to communicate with patients, reduce churn, easily reactivate latent treatment plans and revenue, and accurately track their marketing spending and results.

"We are excited to fully integrate MMG Fusion into the Curve Dental ecosystem," said Jana Macon, Curve Dental's Executive Vice President of Customer Success. "By integrating with a comprehensive patient engagement and practice marketing tracking solution like MMG Fusion, we will provide our customers with the tools they need to get back on their feet quickly, efficiently, and cost effectively."

About Curve Dental

Founded in 2004, Curve Dental provides web-based dental software and related services to dental practices within the United States and Canada. The company is privately-held, with offices in Provo, Utah, and Calgary, Alberta. Curve Dental strives to make dental software less about computers and more about user experience. Their creative thinking can be seen in the design of their software, that's easy to use and built only for the web. Visit www.curvedental.com for more information.

About MMG Fusion

Founded in 2015, MMG Fusion is dedicated to creating innovative technology solutions that help dentists build thriving practices by making front office management and practice marketing simple and intuitive. The MMG Fusion suite of tools, available as all-in-one integrated systems or as separate modules provides management of online marketing, search optimization, social media marketing, online reputation management, patient communications, and engagement, call recording and tracking, schedule optimization and ROI assessment. MMG Fusion is a cloud-based software as a service offering that integrates seamlessly with practice management software presenting information via a single streamlined dashboard interface. Visit www.mmgfusion.com for more information.







Recent Headlines

© 2024 Conexiant | Privacy Policy